Compare Sterling Biotech with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs J.B.CHEMICALS - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH J.B.CHEMICALS STERLING BIOTECH/
J.B.CHEMICALS
 
P/E (TTM) x -0.4 16.8 - View Chart
P/BV x 0.0 2.3 0.6% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 STERLING BIOTECH   J.B.CHEMICALS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
J.B.CHEMICALS
Mar-18
STERLING BIOTECH/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs11363 2.9%   
Low Rs3255 1.3%   
Sales per share (Unadj.) Rs26.8169.1 15.8%  
Earnings per share (Unadj.) Rs-15.016.6 -90.1%  
Cash flow per share (Unadj.) Rs-5.523.4 -23.3%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs54.9172.5 31.8%  
Shares outstanding (eoy) m267.8783.57 320.5%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.31.8 14.2%   
Avg P/E ratio x-0.518.6 -2.5%  
P/CF ratio (eoy) x-1.313.2 -9.6%  
Price / Book Value ratio x0.11.8 7.1%  
Dividend payout %012.0 0.0%   
Avg Mkt Cap Rs m1,86225,827 7.2%   
No. of employees `0001.43.8 35.9%   
Total wages/salary Rs m5472,511 21.8%   
Avg. sales/employee Rs Th5,303.33,747.4 141.5%   
Avg. wages/employee Rs Th403.8665.7 60.7%   
Avg. net profit/employee Rs Th-2,959.0367.8 -804.6%   
INCOME DATA
Net Sales Rs m7,18114,135 50.8%  
Other income Rs m43366 11.6%   
Total revenues Rs m7,22314,501 49.8%   
Gross profit Rs m9472,178 43.5%  
Depreciation Rs m2,543570 446.4%   
Interest Rs m4,37735 12,541.8%   
Profit before tax Rs m-5,9311,940 -305.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924552 -348.4%   
Profit after tax Rs m-4,0071,387 -288.8%  
Gross profit margin %13.215.4 85.6%  
Effective tax rate %32.428.5 113.9%   
Net profit margin %-55.89.8 -568.5%  
BALANCE SHEET DATA
Current assets Rs m14,33510,470 136.9%   
Current liabilities Rs m49,8092,749 1,811.9%   
Net working cap to sales %-494.054.6 -904.4%  
Current ratio x0.33.8 7.6%  
Inventory Days Days40355 730.8%  
Debtors Days Days17178 219.7%  
Net fixed assets Rs m55,4325,811 953.9%   
Share capital Rs m268167 160.3%   
"Free" reserves Rs m13,93514,248 97.8%   
Net worth Rs m14,70114,416 102.0%   
Long term debt Rs m9,4780-   
Total assets Rs m73,98817,649 419.2%  
Interest coverage x-0.456.6 -0.6%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.10.8 12.1%   
Return on assets %0.58.1 6.2%  
Return on equity %-27.39.6 -283.2%  
Return on capital %-6.413.7 -46.9%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8606,164 30.2%   
Fx outflow Rs m251,334 1.9%   
Net fx Rs m1,8354,829 38.0%   
CASH FLOW
From Operations Rs m1,7191,231 139.7%  
From Investments Rs m-3,148-208 1,512.8%  
From Financial Activity Rs m1,426-595 -239.6%  
Net Cashflow Rs m-3427 -0.8%  

Share Holding

Indian Promoters % 33.9 55.4 61.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.0 3.4 -  
FIIs % 9.9 3.9 253.8%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 37.0 106.2%  
Shareholders   21,482 30,437 70.6%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS